[1]季晓军,王洪生,殷尚炯,等.超剂量替加环素治疗广泛耐药鲍曼不动杆菌颅内感染1例报告并文献回顾[J].临床神经外科杂志,2020,17(04):473-476.[doi:DOI:10.3969/j.issn.1672-7770.2020.04.027]
 JI Xiao-jun,WANG Hong-sheng,YIN Shang-jiong,et al.Treatment of intracranial infection with extensively drug resistant Acinetobacter baumanni by using high-dose tigecycline(report of one case and review of literature )[J].Journal of Clinical Neurosurgery,2020,17(04):473-476.[doi:DOI:10.3969/j.issn.1672-7770.2020.04.027]
点击复制

超剂量替加环素治疗广泛耐药鲍曼不动杆菌颅内感染1例报告并文献回顾()
分享到:

《临床神经外科杂志》[ISSN:1672-7770/CN:32-1727/R]

卷:
17
期数:
2020年04期
页码:
473-476
栏目:
病例报告
出版日期:
2020-08-14

文章信息/Info

Title:
Treatment of intracranial infection with extensively drug resistant Acinetobacter baumanni by using high-dose tigecycline(report of one case and review of literature )
文章编号:
202004027
作者:
季晓军王洪生殷尚炯王阳春付强
075000 张家口,中国人民解放军陆军第八十一集团军医院神经外科
Author(s):
JI Xiao-jun WANG Hong-sheng YIN Shang-jiong et al.
Department of Neurosurgery, the Hospital of 81 st Group Army PLA, Zhangjiakou 075000, China
关键词:
替加环素超剂量广泛耐药鲍曼不动杆菌颅内感染
Keywords:
tigecycline high-dose extensively drug resistant Acinetobacter baumanni intracranial infection
分类号:
R651.1
DOI:
DOI:10.3969/j.issn.1672-7770.2020.04.027
文献标志码:
B
摘要:
目的探讨超剂量替加环素对广泛耐药鲍曼不动杆菌(XDRAB) 颅内感染的治疗效果。方法回顾性分析1例XDRAB颅内感染患者的临床资料,重点对应用超剂量替加环素治疗过程进行分析。并对相关文献进行复习。结果患者XDRAB颅内感染发生后,开始用常规剂量替加环素静脉治疗无效。通过调整治疗方案为超剂量替加环素静脉用药后,颅内感染得到控制并治愈。结论超剂量替加环素静脉应用对XDRAB致颅内感染可取得良好的治疗效果。
Abstract:
To explore the therapeutic effects of intracranial infection with extensively drug resistant Acinetobacter baumanni(XDRAB) by using high-dose tigecycline. Methods The clinical data of 1 case of intracranial infection with XDRAB, especially the treatment process of using high-dose tigecycline,were analyzed retrospectively and the related literatures were reviewed.Results After the occurence of XDRAB intracranial infection, intravenous administration of tigecycline at regular dose was ineffective. The intracranial infection was controlled and cured by adjusting the therapeutic schedule to intravenous high-dose tigecycline. Conclusion Intravenous high-dose tigecycline can achieve good therapeutic effects for the intracranial infection with XDRAB.

相似文献/References:

[1]夏博铭,朱磊,张恒柱,等.多途径联合用药治疗广泛耐药鲍曼不动杆菌颅内感染1例报告并文献复习[J].临床神经外科杂志,2019,16(3):266.[doi:10.3969/j.issn.1672-7770.2019.03.018]
 XIA Bo-ming,ZHU Lei,ZHANG Heng-zhu,et al.Multi-routes administration therapy for intracranial infection with extensively drug-resistant Acinetobacter baumannii(report of a case and review of literature)[J].Journal of Clinical Neurosurgery,2019,16(04):266.[doi:10.3969/j.issn.1672-7770.2019.03.018]
[2]焦永成,孔海波,刘爱军,等.替加环素鞘内注射治疗多重耐药鲍曼不动杆菌颅内感染[J].临床神经外科杂志,2020,17(01):90.[doi:DOI:10.3969/j.issn.1672-7770.2020.01.020]
 JIAO Yong-cheng,KONG Hai-bo,LIU Ai-jun,et al.Tigecycline intrathecally administration on intracranial infection of multiple drug resistant Acinetobacter Baumannii[J].Journal of Clinical Neurosurgery,2020,17(04):90.[doi:DOI:10.3969/j.issn.1672-7770.2020.01.020]

更新日期/Last Update: 2020-08-18